AstraZeneca On Tagrisso's Milestone Advance Into Adjuvant Lung Cancer

 
• By Jessica Merrill
Astrazeneca
AstraZeneca's Tagrisso is approved in adjuvant NSCLC • Source: Shutterstock

More from Anticancer

More from Therapeutic Category